Jeff Cooper: Is Biotech Going Bust?
Biotech has been the speculative driver in this market. Is That About to Change?
These include Receptos (RCPT), Medivation (MDVN), Bluebird (BLUE), and Incyte (INCY) to mention a few.
IBB broke out of a short-term bull flag on its dailies and looks poised to extend.
However, a look at the weeklies suggest it may be vulnerable:
The last time IBB closed above its upper weekly Bollinger Band after a long rally was in January 2014. A 20% correction followed.
Note the gap up to the early 2014 high that preceded the top.
When IBB offset the gap, accelerated downside momentum resulted.
We should be alert for a fractal of this pattern if IBB offsets yesterday's gap.
In other words, if IBB quickly fills yesterday's gap and continues to trade lower, it is probably a good warning sign.
Let's take a look at IBB time and price vibrations.
From a low of 59 in 2008, six revs (of 360 degrees) up is 386.
Note how that ties to the 275 peak in early 2014 that preceded the 20% correction.
The last big swing low at 207/208 ties to March 6.
Note the consolidation at 338ish which is 2 revs up from 207ish.
Click to enlarge
If you are interested in purchasing a physical Square of 9 Chart, which includes a consultation on its use, please email firstname.lastname@example.org.
Conclusion. IBB may be starting a new leg up but a move back below 338 looks near term bearish.
345 is one rev up from the 275 and should elicit some digestion.
A reversal in IBB back below Thursday's gap and back below the recent little bull flag should be a harbinger of a correction in the popular indices.
Click here to take a FREE 14-day trial to Jeff Cooper's Daily Market Report, which will give you Jeff's top picks in real time.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter